Trial intelligence / Profile preview

GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

NCT02075463Phase 2Terminated

Sponsor
GSK
Start
Jun 2014
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of daprodustat in anemia, sponsored by GSK. Started Jun 2014; status: terminated.

02

Drugs

daprodustat
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02075463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02075463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call